Form 4 for FLGT Fulgent Genetics, Inc.
Accepted 2025-05-19 00:00:00 ET · period of report 2025-05-15 · accession 0000950170-25-074602 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-19 | 2025-05-15 | FLGT | Nohaile Michael | Dir | A - Grant | $0.00 | +4,491 | 19.0K | +31% | $0 |
| D | 2025-05-19 | 2025-05-15 | FLGT | Nohaile Michael | Dir | A - Grant | $0.00 | +6,311 | 6,311 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-15 | A | A | 4,491 | $0.00 | 19,020 | D | — | — | (F1) Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 15, 2025, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-05-15 | A | A | 6,311 | $0.00 | 6,311 | D | $20.04 · — to 2035-05-14 | 6,311 Common Stock | (F2) The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 15, 2025, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date. |